{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T04:38:17Z","timestamp":1771648697053,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T00:00:00Z","timestamp":1597017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T00:00:00Z","timestamp":1597017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Merz Pharmaceuticals GmbH"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s12325-020-01427-6","type":"journal-article","created":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T17:05:06Z","timestamp":1597079106000},"page":"4249-4265","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["IncobotulinumtoxinA for the Treatment of Blepharospasm in Toxin-Na\u00efve Subjects: A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial"],"prefix":"10.1007","volume":"37","clinical-trial-number":[{"clinical-trial-number":"nct01896895","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4691-3388","authenticated-orcid":false,"given":"Dimos D.","family":"Mitsikostas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Dekundy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kati","family":"Sternberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Althaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Pagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,10]]},"reference":[{"key":"1427_CR1","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1002\/mds.26934","volume":"32","author":"G Defazio","year":"2017","unstructured":"Defazio G, Hallett M, Jinnah HA, Conte A, Berardelli A. Blepharospasm 40\u00a0years later. Mov Disord. 2017;32:498\u2013509.","journal-title":"Mov Disord"},{"key":"1427_CR2","doi-asserted-by":"publisher","unstructured":"Costa J, Esp\u00edrito-Santo C, Borges A, et al. Botulinum toxin type A therapy for blepharospasm. Cochrane Database Syst Rev. 2005. https:\/\/doi.org\/10.1002\/14651858.CD004900.pub2","DOI":"10.1002\/14651858.CD004900.pub2"},{"key":"1427_CR3","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1002\/mds.25244","volume":"27","author":"TD Steeves","year":"2012","unstructured":"Steeves TD, Day L, Dykeman J, Jette N, Pringsheim T. The prevalence of primary dystonia: a systematic review and meta-analysis. Mov Disord. 2012;27:1789\u201396.","journal-title":"Mov Disord"},{"key":"1427_CR4","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/00002341-199809000-00002","volume":"14","author":"RL Anderson","year":"1998","unstructured":"Anderson RL, Patel BC, Holds JB, Jordan DR. Blepharospasm: past, present, and future. Ophthalmic Plast Reconstr Surg. 1998;14:305\u201317.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"1427_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.5693\/djo.01.2016.11.001","volume":"23","author":"J Clark","year":"2017","unstructured":"Clark J, Randolph J, Sokol JA, Moore NA, Lee HBH, Nunery WR. Surgical approach to limiting skin contracture following protractor myectomy for essential blepharospasm. Digit J Ophthalmol. 2017;23:8\u201312.","journal-title":"Digit J Ophthalmol."},{"key":"1427_CR6","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1002\/mds.23658","volume":"26","author":"J Jankovic","year":"2011","unstructured":"Jankovic J, Comella C, Hanschmann A, Grafe S. Efficacy and safety of incobotulinumtoxinA (NT 201, Xeomin) in the treatment of blepharospasm\u2014a randomized trial. Mov Disord. 2011;26:1521\u20138.","journal-title":"Mov Disord"},{"key":"1427_CR7","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1007\/s00702-013-0998-9","volume":"120","author":"DD Truong","year":"2013","unstructured":"Truong DD, Gollomp SM, Jankovic J, et al. Sustained efficacy and safety of repeated incobotulinumtoxinA (Xeomin\u00ae) injections in blepharospasm. J Neural Transm (Vienna). 2013;120:1345\u201353.","journal-title":"J Neural Transm (Vienna)."},{"key":"1427_CR8","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00702-005-0323-3","volume":"113","author":"P Roggenk\u00e4mper","year":"2006","unstructured":"Roggenk\u00e4mper P, Jost WH, Bihari K, Comes G, Grafe S, NT 201 Blepharospasm Study Team. Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm. J Neural Transm (Vienna). 2006;113:303\u201312.","journal-title":"J Neural Transm (Vienna)."},{"issue":"Suppl 1","key":"1427_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/PL00007813","volume":"248","author":"WH Jost","year":"2001","unstructured":"Jost WH, Kohl A. Botulinum toxin: evidence-based medicine criteria in blepharospasm and hemifacial spasm. J Neurol. 2001;248(Suppl 1):21\u20134.","journal-title":"J Neurol"},{"key":"1427_CR10","unstructured":"Merz Pharma UK Ltd. XEOMIN\u00ae (50\/100\/200) Summary of Product Characteristics. 2017. http:\/\/www.medicines.org.uk\/emc\/medicine\/24582. Accessed 17 May 2019."},{"key":"1427_CR11","unstructured":"Merz Pharmaceuticals LLC. Highlights of Prescribing Information\u2014Xeomin\u00ae. 2019. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/125360s074lbl.pdf. Accessed 17 May 2019."},{"key":"1427_CR12","unstructured":"AAN (American Academy of Neurology). Clinical practice guideline process manual. St. Paul: American Academy of Neurology; 2004."},{"key":"1427_CR13","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1212\/WNL.0000000000002560","volume":"86","author":"DM Simpson","year":"2016","unstructured":"Simpson DM, Hallett M, Ashman EJ, et al. Practice guideline update summary: botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2016;86:1818\u201326.","journal-title":"Neurology."},{"key":"1427_CR14","doi-asserted-by":"publisher","first-page":"E332","DOI":"10.3390\/toxins12050332","volume":"12","author":"LL Spiegel","year":"2020","unstructured":"Spiegel LL, Ostrem JL, Bledsoe IO. FDA approvals and consensus guidelines for botulinum toxins in the treatment of dystonia. Toxins (Basel). 2020;12:E332.","journal-title":"Toxins (Basel)."},{"key":"1427_CR15","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/mds.22368","volume":"24","author":"J Jankovic","year":"2009","unstructured":"Jankovic J, Kenney C, Grafe S, Goertelmeyer R, Comes G. Relationship between various clinical outcome assessments in patients with blepharospasm. Mov Disord. 2009;24:407\u201313.","journal-title":"Mov Disord"},{"key":"1427_CR16","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s00702-010-0546-9","volume":"118","author":"B Wabbels","year":"2011","unstructured":"Wabbels B, Jost WH, Roggenk\u00e4mper P. Difficulties with differentiating botulinum toxin treatment effects in essential blepharospasm. J Neural Transm (Vienna). 2011;118:925\u201343.","journal-title":"J Neural Transm (Vienna)."},{"key":"1427_CR17","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.2147\/DDDT.S79193","volume":"9","author":"WH Jost","year":"2015","unstructured":"Jost WH, Benecke R, Hauschke D, et al. Clinical and pharmacological properties of incobotulinumtoxinA and its use in neurological disorders. Drug Des Dev Ther. 2015;9:1913\u201326.","journal-title":"Drug Des Dev Ther."},{"key":"1427_CR18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/S0885-3924(00)00146-9","volume":"20","author":"J Wissel","year":"2000","unstructured":"Wissel J, M\u00fcller J, Dressnandt J, et al. Management of spasticity associated pain with botulinum toxin A. J Pain Symptom Manag. 2000;20:44\u20139.","journal-title":"J Pain Symptom Manag"},{"key":"1427_CR19","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00702-010-0529-x","volume":"118","author":"B Wabbels","year":"2011","unstructured":"Wabbels B, Reichel G, Fulford-Smith A, Wright N, Roggenk\u00e4mper P. Double-blind, randomised, parallel group pilot study comparing two botulinum toxin type A products for the treatment of blepharospasm. J Neural Transm (Vienna). 2011;118:233\u20139.","journal-title":"J Neural Transm (Vienna)."},{"key":"1427_CR20","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/WNO.0000000000000110","volume":"34","author":"J Saad","year":"2014","unstructured":"Saad J, Gourdeau A. A direct comparison of onabotulinumtoxinA (Botox) and incobotulinumtoxinA (Xeomin) in the treatment of benign essential blepharospasm: a split-face technique. J Neuroophthalmol. 2014;34:233\u20136.","journal-title":"J Neuroophthalmol"},{"key":"1427_CR21","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1177\/0333102410391485","volume":"31","author":"DD Mitsikostas","year":"2011","unstructured":"Mitsikostas DD, Mantonakis LI, Chalarakis NG. Nocebo is the enemy, not placebo. A meta-analysis of reported side effects after placebo treatment in headaches. Cephalalgia. 2011;31:550\u201361.","journal-title":"Cephalalgia."},{"key":"1427_CR22","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1177\/1352458510370793","volume":"16","author":"D Papadopoulos","year":"2010","unstructured":"Papadopoulos D, Mitsikostas DD. Nocebo effects in multiple sclerosis trials: a meta-analysis. Mult Scler. 2010;16:816\u201328.","journal-title":"Mult Scler."},{"key":"1427_CR23","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.psychres.2013.10.019","volume":"215","author":"DD Mitsikostas","year":"2014","unstructured":"Mitsikostas DD, Mantonakis L, Chalarakis N. Nocebo in clinical trials for depression: a meta-analysis. Psychiatry Res. 2014;215:82\u20136.","journal-title":"Psychiatry Res"},{"key":"1427_CR24","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1007\/s00702-013-1048-3","volume":"120","author":"VGH Evidente","year":"2013","unstructured":"Evidente VGH, Fernandez HH, LeDoux MS, et al. A randomized, double-blind study of repeated incobotulinumtoxinA (Xeomin\u00ae) in cervical dystonia. J Neural Transm (Vienna). 2013;120:1699\u2013707.","journal-title":"J Neural Transm (Vienna)."}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-020-01427-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-020-01427-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-020-01427-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T16:33:58Z","timestamp":1628613238000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-020-01427-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,10]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["1427"],"URL":"https:\/\/doi.org\/10.1007\/s12325-020-01427-6","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,10]]},"assertion":[{"value":"29 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}